Owing to previous studies showing that I/R injury mechanisms are similar in a variety of tissue types13 and patients with APS having a greater risk of myocardial infarction,24 one may hypothesise that aPL antibodies play a pathogenic role also in the setting of the myocardium. The gene discussed is FASLG; the disease is myocardial infarction.